Annals of Pharmacotherapy

From WikiMD's WELLNESSPEDIA


Annals of Pharmacotherapy

The Annals of Pharmacotherapy is a peer-reviewed medical journal that focuses on the field of pharmacotherapy. It publishes articles related to the safe, effective, and economical use of medications in patient care.

History[edit]

The journal was established in 1967 under the name "Drug Intelligence & Clinical Pharmacy". In 1992, it was renamed to "The Annals of Pharmacotherapy" to better reflect its focus on the comprehensive aspects of pharmacotherapy.

Scope[edit]

The Annals of Pharmacotherapy covers a wide range of topics within the field of pharmacotherapy, including but not limited to:

  • Clinical pharmacology
  • Pharmacokinetics
  • Pharmacodynamics
  • Drug interactions
  • Adverse drug reactions
  • Pharmacoeconomics
  • Pharmacogenomics

Editorial Process[edit]

The journal employs a rigorous peer-review process to ensure the quality and relevance of its publications. Manuscripts are reviewed by experts in the field, and decisions are made based on the scientific merit and contribution to the field of pharmacotherapy.

Publication Frequency[edit]

The Annals of Pharmacotherapy is published monthly, providing timely updates and research findings to healthcare professionals, researchers, and academics.

Related Pages[edit]

External Links[edit]

Stub icon 1 Stub icon 2

This article about a pharmacology journal is a stub. You can help WikiMD by expanding the page.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Annals_of_Pharmacotherapy&oldid=6614286"